Our Scientific Director Dr David Flavell explains about the life saving research work being conducted by Leukaemia Busters scientists and doctors.
At the heart of Leukaemia Busters research is The Simon Flavell Leukaemia Research Laboratory at Southampton General Hospital. Here there has been a continuous stream of high quality research since 1991 that has led to the development of several antibody-based drugs for leukaemia and lymphoma. Leukaemia Busters doctors and scientists have successfully investigated two of these in early phase clinical trials in adults and children with leukaemia, lymphoma and myeloma.
We currently have two major laboratory-based research objectives, firstly the development of genetically engineered immunotoxins for use in clinical studies and secondly exploring ways of improving the potency of our immunotoxins.
By adopting this two pronged approach we anticipate being able to develop innovative and groundbreaking treatments that will ensure the destruction of leukaemia or lymphoma cells in the patients body without the nasty side effects associated with conventional chemotherapy.